Goldman Sachs
ERAS icon

Goldman Sachs’s Erasca ERAS Stock Holding History

Goldman Sachs’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.9M Buy
4,875,186
+1,543,768
+46% +$18.2M 0.01% 1212
2025
Q4 		$12.4M Buy
3,331,418
+814,230
+32% +$2.29M ﹤0.01% 2875
2025
Q3 		$5.49M Buy
2,517,188
+697,339
+38% +$1.11M ﹤0.01% 3553
2025
Q2 		$2.31M Sell
1,819,849
-116,408
-6% -$156K ﹤0.01% 4063
2025
Q1 		$2.65M Sell
1,936,257
-865,373
-31% -$1.49M ﹤0.01% 3916
2024
Q4 		$7.03M Sell
2,801,630
-428,726
-13% -$1.18M ﹤0.01% 3118
2024
Q3 		$8.82M Buy
3,230,356
+1,037,720
+47% +$2.92M ﹤0.01% 2847
2024
Q2 		$5.17M Buy
2,192,636
+610,620
+39% +$1.32M ﹤0.01% 3121
2024
Q1 		$3.26M Buy
1,582,016
+284,974
+22% +$570K ﹤0.01% 3475
2023
Q4 		$2.76M Buy
1,297,042
+633,192
+95% +$1.34M ﹤0.01% 3670
2023
Q3 		$1.31M Buy
663,850
+34,348
+5% +$88K ﹤0.01% 4078
2023
Q2 		$1.74M Sell
629,502
-98,897
-14% -$282K ﹤0.01% 3974
2023
Q1 		$2.19M Buy
728,399
+270,294
+59% +$983K ﹤0.01% 3785
2022
Q4 		$1.97M Sell
458,105
-947,512
-67% -$6.42M ﹤0.01% 3955
2022
Q3 		$11M Buy
1,405,617
+964,234
+218% +$7.77M ﹤0.01% 2421
2022
Q2 		$2.46M Buy
441,383
+96,643
+28% +$633K ﹤0.01% 3860
2022
Q1 		$2.96M Buy
344,740
+274,504
+391% +$3.18M ﹤0.01% 3873
2021
Q4 		$1.09M Buy
+70,236
New +$1.2M ﹤0.01% 4766

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Goldman Sachs's ERAS Position: Q1 2026 in Review

Goldman Sachs increased its Erasca (ERAS) stake by 46% in Q1 2026, buying an estimated $18.2M and bringing the position to 4,875,186 shares worth $78.9M. The position accounts for 0.01% of the portfolio, ranked #1212.

Goldman Sachs first reported a position in ERAS in Q4 2021 and has held it in 18 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Goldman Sachs held 4,875,186 shares of Erasca worth $78.9M as of Q1 2026.
  • Goldman Sachs bought 1,543,768 Erasca shares in Q1 2026, an estimated $18.2M.
  • Erasca made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1212 holding.
  • Goldman Sachs first reported a position in Erasca in Q4 2021 and has held it in 18 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.